Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
Ángeles Vinuesa, Carlos Pomilio, Amal Gregosa, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
Immacolata Vecchio, Luca Sorrentino, Anna Maria Paoletti, et al.
Journal of Central Nervous System Disease (2021) Vol. 13
Open Access | Times Cited: 111
TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target
Li Ruiyang, Qi Qin, Han-Chen Yang, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 110
A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 43
Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration
Jialiu Zeng, Lenny Yi Tong Cheong, Chih Hung Lo
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 3
Body and mind: how obesity triggers neuropsychiatric and neurodegenerative disorders
Claudio Pirozzi, Nicola Opallo, Filomena Del Piano, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access | Times Cited: 2
AdipoRon’s Impact on Alzheimer’s Disease—A Systematic Review and Meta-Analysis
Sandra Maria Barbalho, Lucas Fornari Laurindo, Bárbara de Oliveira Zanuso, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 484-484
Open Access | Times Cited: 2
Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding
William B. Grant, Steven M. Blake
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1353-1382
Open Access | Times Cited: 25
Role of metabolic dysfunction and inflammation along the liver–brain axis in animal models with obesity-induced neurodegeneration
Evridiki Asimakidou, Eka Norfaishanty Saipuljumri, Chih Hung Lo, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 4, pp. 1069-1076
Open Access | Times Cited: 10
Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
Jeffrey L. Cummings, Andrew A. Ortiz, Janelle Castellino, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5727-5757
Open Access | Times Cited: 32
Cell membrane-based nanomaterials for therapeutics of neurodegenerative diseases
Phuong‐Trang Nguyen‐Thi, Thuy Trang Nguyen, Hoàng Long Phan, et al.
Neurochemistry International (2023) Vol. 170, pp. 105612-105612
Closed Access | Times Cited: 19
Insulin resistance as the molecular link between diabetes and Alzheimer's disease
Mona Mohamed Ibrahim Abdalla
World Journal of Diabetes (2024) Vol. 15, Iss. 7, pp. 1430-1447
Open Access | Times Cited: 8
PARP-1-Associated Pathological Processes: Inhibition by Natural Polyphenols
Natalya Maluchenko, Alexey V. Feofanov, Vasily M. Studitsky
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11441-11441
Open Access | Times Cited: 34
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
Saghar Rabiei Poor, Miren Ettcheto, Amanda Cano, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 890-890
Open Access | Times Cited: 33
Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection
Sananda Dey, Nensina Murmu, Tanushree Mondal, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113801-113801
Open Access | Times Cited: 27
Necroptosis in Alzheimer’s disease: Potential therapeutic target
Riane Richard, Shaker A. Mousa
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113203-113203
Open Access | Times Cited: 24
The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease
Ancuța-Veronica Lupăescu, Monica Iavorschi, Mihai Covașă
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 235-235
Open Access | Times Cited: 23
Alteration in the number of neuronal and non-neuronal cells in mouse models of obesity
Mayara M Andrade, Caroline Fernandes, Letícia Forny‐Germano, et al.
Brain Communications (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 14
Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation
Violina Kakoty, Sarathlal KC, Shobha Kumari, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 699-716
Closed Access | Times Cited: 14
Gut microbiome-based therapies for alleviating cognitive impairment: state of the field, limitations, and future perspectives
Linli Bu, Chen Wang, Junying Bai, et al.
Food & Function (2024) Vol. 15, Iss. 3, pp. 1116-1134
Closed Access | Times Cited: 5
A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer’s Disease
William B. Grant
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. s1, pp. S165-S178
Open Access | Times Cited: 5
Review: Effect of essential fatty acids and conjugated linoleic acid on the adaptive physiology of dairy cows during the transition period
A Veshkini, Fabrizio Ceciliani, Muriel Bonnet, et al.
animal (2023) Vol. 17, pp. 100757-100757
Open Access | Times Cited: 12
Investigating metabolic characteristics of type 2 diabetes mellitus-related cognitive dysfunction and correlating therapeutic effects of Di Dang Tang in animal models
Changting Sheng, Rensong Yue
Journal of Ethnopharmacology (2025), pp. 119338-119338
Closed Access
Health-promoting effects of cinnamon
Nisha Yadav, Neha Saini, Nitika Rathi, et al.
Elsevier eBooks (2025), pp. 219-241
Closed Access
Sex-Specific Links Between Low Choline, Metabolic Dysfunction, and Neuropathology in Obesity: Insights from Humans and the 3xTg-AD Mouse Model of Alzheimer's disease.
Wendy Winslow, Jessica M. Judd, Savannah Tallino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Metformin as a disease-modifying therapy in osteoarthritis: bridging metabolism and joint health
Iryna Halabitska, Pavlo Petakh, Oleksandr Kamyshnyi
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top